Gelenk- und Sportklinik Rhein/Ruhr continues growth with Ortivity
Livingstone has advised the orthopedic practice group MVZ GSK Rhein/Ruhr GmbH on the sale of a majority stake to Ortivity GmbH, a portfolio company of Apheon Capital. The partnership aims to strengthen the fast-growing medical care center (MVZ) with its affiliated private clinic in further tapping the high potential of outpatient care in the healthcare sector. The founders and managing partners Drs. Husain, Peszko and Wilsenack will retain a significant stake in the MVZ Group.
MVZ GSK Rhein/Ruhr was founded in 2015 by Drs. Husain, Peszko and Wilsenack and runs two orthopedic and sports medicine practices in Mülheim a.d. Ruhr and Essen in Germany as well as a state-of-the-art surgery center. The Ortivity Group, part of the portfolio of investment company Apheon Capital, has made a majority investment in the MVZ GSK Rhein/Ruhr and the private clinic it operates. Just four years after its founding, over 47,000 respondents voted the private clinic into the top 5 of all German sports clinics, and MVZ GSK Rhein/Ruhr was named the best sports clinic in Germany in the Handelsblatt Clinic Ranking in 2023.
Since its foundation, the group has grown significantly and is now one of the regional centers for conservative sports medicine and surgical care in the area around Mülheim. Today, the MVZ GSK Rhein/Ruhr employs more than 50 staff and specialists in the fields of general orthopedics, general surgery, foot surgery, sports medicine, pain therapy, trauma surgery and anesthesiology. The merger with the orthopedic group Ortivity gives MVZ GSK Rhein/Ruhr access to a high number of practice locations in the Ruhr region and the Rhineland, complementing Ortivity’s range of services.
“The current developments regarding outpatient care in the healthcare sector are leading to major changes in the performance of a large number of orthopedic and sports medicine procedures that can no longer be performed on an inpatient basis. In Ortivity, we have found a partner who will support us in seizing the resulting opportunities for our group even better,” said Dr. B. Husain, co-founder and managing partner of MVZ GSK Rhein/Ruhr.
“We are very pleased to have gained a strong partner in the field of surgical care with MVZ GSK Rhein/Ruhr and to be able to lay another important cornerstone in increasing the Group’s enormous surgical potential. The MVZ GSK Rhein/Ruhr is an ideal addition to our largest network structure in the Rhineland and Ruhr region and is a valuable strategic component of the Group’s further growth, especially in view of outpatient care,” added Konrad Kofen, Head of M&A at Ortivity.
Dr. A. Peszko, co-founder and managing partner of MVZ GSK Rhein/Ruhr, said: “Throughout the entire transaction, Livingstone’s healthcare team guided us very well through the complex negotiation process and always gave us the necessary security in what was an unusual step for us. From the extensive preparation of the transaction to the final signature and beyond, we achieved an optimal negotiation result with our new partner thanks to the consistently competent support of Christian Grandin, Philip Dorsemagen and Felix Baust.”
Christian Grandin, Managing Partner at Livingstone, commented: “Supporting large MVZs requires in-depth knowledge of the highly regulated healthcare sector and a good understanding of the special features of the medical environment. We are very pleased that we were able to bring our experience to bear in another transaction in the field of orthopedics and anesthesia.”
This marks the 16th successful transaction by Livingstone’s Healthcare team in the ongoing fiscal year 2023, following, among others, the sale of Physio CKI to Kapital 1852, the three successful sales for Centers for Autism & Related Disorders, LLC, and the financing and acquisition of CAM Bioceramics B.V. by SHS Capital.
